RWE’s moment: What COVID-19 means for you

­

Septiembre, 2020

24Sep5:00 pm- 6:00 pmRWE’s moment: What COVID-19 means for youwebinar

Detalles del evento

Driven by the COVID-19 pandemic, a new hunger for insight has spiked the appetite for real-world evidence (RWE) across our industry.

Regulators have turned to RWE in the search for an effective COVID-19 treatment and to pass new emergency use approvals. Innovative payers and providers now use data sources once considered “untested” (e.g. wearable devices, smartphone diagnostic tools) to collect evidence about their populations, understand symptom progression, and better detect at-risk individuals. While HTAs are increasingly incorporating RWE into value assessments to inform price and access decisions.

And don’t be mistaken. This hunger is here to stay. You must strengthen your evidence generation strategies now to meet these growing demands or fall behind adaptive competition.

Yet optimizing internal RWE strategies and functions is easier said than done. COVID-19 has not erased the evidence generation challenges faced before. You must then go beyond the status quo of piece-meal RWE efforts and cross-functional collaboration to overcome legacy data and operational silos, and to improve efficacy and impact of RWE studies.

Hora

(Jueves) 5:00 pm - 6:00 pm

Location

Webinar

Organizado por

Reuters Events

Deje su comentario

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.